首页> 外文期刊>Pathology >Detection and incidence of Bordetella holmesii in respiratory specimens from patients with pertussis-like symptoms in New South Wales, Australia
【24h】

Detection and incidence of Bordetella holmesii in respiratory specimens from patients with pertussis-like symptoms in New South Wales, Australia

机译:澳大利亚新南威尔士患者患者呼吸样本中呼吸标本中Bordetella holmesii的检测和发病率

获取原文
获取原文并翻译 | 示例
           

摘要

Bordetella pertussis, the aetiological agent of whooping cough is routinely diagnosed by polymerase chain reaction (PCR) directed at IS481, an insertion sequence target also found in Bordetella holmesii. Recent reports have suggested that B. holmesii infections can be misdiagnosed as pertussis, which can have a significant impact on public health surveillance. This study investigated the presence of B. holmesii in B. pertussis positive clinical samples, in order to determine the incidence of B. holmesii. Clinical cases of pertussis diagnosed by IS481-specific PCR between October 2008 and March 2016 in New South Wales were included. Bordetella holmesii was detected through the simultaneous amplification of IS481 and B. holmesii specific insertions sequence, hIS1001. A total of 46 of 802 patients were identified to be positive for B. holmesii rather than B. pertussis, suggesting an incidence rate of 6.5% in 2009, 16.8% in 2010, 7.6% during 2013 and 8.1% during 2015. Bordetella holmesii infections were diagnosed during and between pertussis epidemics, however cases of B. holmesii and B. pertussis co-infections were not found. The predominant age group of B. holmesii infection was 11-18 years old, which was significantly different to the mean age of B. pertussis infections (0-6 years, p = 0.023). These findings revealed that B. holmesii was co-circulating alongside the B. pertussis epidemic for seven years, hidden from view, as B. holmesii infections have been diagnosed as B. pertussis. Confirmatory testing of B. pertussis positive samples for the presence of B. holmesii, especially during pertussis epidemics, should improve the quality of laboratory diagnosis and laboratory surveillance for pertussis. The presence of B. holmesii in Australia highlights the importance of testing for this pathogen and ongoing molecular surveillance that can guide the control of whooping cough.
机译:Bordetella Pertussis,迄今为止通过聚合酶链反应(PCR)诊断为IS481的ATO481,在Bordetella Holmesii中发现的插入序列靶标经常诊断。最近的报道表明B.Holmesii感染可能被误诊为百日咳,这可能对公共卫生监测产生重大影响。本研究研究了B.Pertussis阳性临床样品B. Holmesii的存在,以确定B. Holmesii的发病率。包括在2008年10月至2016年3月在新南威尔士州诊断的临床病例。通过同时扩增IS481和B.Holmesii特异性插入序列来检测Bordetella Holmesii,His1001。鉴定了802名患者中的46例为B. Holmesii而不是B.Pertussis阳性,建议2009年的发病率为6.5%,2010年的16.8%,2013年的7.6%和2015年期间8.1%.Bordetella Holmesii感染在Pertussis流行病期间诊断出,然而,没有发现B.Holmesii和B.Pertussis的同期。 B.Holmesii感染的主要年龄组为11-18岁,与B.Pertussis感染的平均年龄有显着差异(0-6岁,P = 0.023)。这些发现透露,B. Holmesii与七年来,隐藏的B.Pertussis疫情与视野隐藏起来,因为B.Holmesii感染被诊断为B. Pertussis。 B.Pertussis阳性样品的确认测试B. Holmesii的存在,特别是在Pertussis流行病期间,应提高百日咳的实验室诊断和实验室监测的质量。 B. Holmesii在澳大利亚的存在凸显了测试该病原体和持续的分子监测的重要性,可以指导呼吸咳嗽的控制。

著录项

  • 来源
    《Pathology》 |2018年第3期|共5页
  • 作者单位

    Westmead Hosp Inst Clin Pathol &

    Med Res NSW Hlth Pathol Ctr Infect Dis &

    Microbiol Publ Hlth;

    Westmead Hosp Inst Clin Pathol &

    Med Res NSW Hlth Pathol Ctr Infect Dis &

    Microbiol Publ Hlth;

    Westmead Hosp Inst Clin Pathol &

    Med Res NSW Hlth Pathol Ctr Infect Dis &

    Microbiol Publ Hlth;

    Westmead Hosp Inst Clin Pathol &

    Med Res NSW Hlth Pathol Ctr Infect Dis &

    Microbiol Publ Hlth;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 病理学;
  • 关键词

    Pertussis; Bordetella holmesii; PCR; Bordetella pertussis;

    机译:Pertussis;Bordetella holmesii;PCR;Bordetella Pertussis;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号